Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/11/2000 | WO2000026245A2 Human membrane transport proteins |
05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
05/11/2000 | WO2000026230A1 Low allergenic protein variants |
05/11/2000 | WO2000026227A1 Ldl related protein and uses thereof |
05/11/2000 | WO2000026226A1 Multidomain polynucleotide molecular sensors |
05/11/2000 | WO2000025936A1 Method for controlled electrostatic adherent deposition of particles on a substrate |
05/11/2000 | WO2000025922A2 Multi-well microfiltration apparatus |
05/11/2000 | WO2000025920A1 Ultrathin-walled multiwell plate for heat block thermocycling |
05/11/2000 | WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
05/11/2000 | WO2000025818A1 asuE/trmU |
05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
05/11/2000 | WO2000025804A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
05/11/2000 | WO2000025800A1 Steroid receptor rna activator |
05/11/2000 | WO2000025798A1 Treatment of parkinson's disease with oligonucleotides |
05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
05/11/2000 | WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
05/11/2000 | WO2000025578A2 Methods for cloning animals |
05/11/2000 | WO2000025574A1 Production of biomedical peptides and proteins in plants using plant virus vectors |
05/11/2000 | WO2000018783B1 Mammaglobin, a secreted mammary-specific breast cancer protein |
05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
05/11/2000 | WO2000009729A3 Expression of chitin synthase and chitin deacetylase genes in plants to alter the cell wall for industrial uses and improved disease resistance |
05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
05/11/2000 | WO2000009656A3 Transgenic plants expressing a dual-specificity mapk phosphatase and uses thereof |
05/11/2000 | WO2000008204A3 Process for identification of substances modulating urei dependent mechanisms of helicobacter pylori metabolism |
05/11/2000 | WO2000008189A3 Plant resistance gene |
05/11/2000 | WO2000008164A3 Thermostable in vitro complex with polymerase activity |
05/11/2000 | WO2000008159A3 Production and use of modified cystatins |
05/11/2000 | WO2000008158A3 Molecules designated ldcam |
05/11/2000 | WO2000008156A3 Dna replication- and repair-associated proteins |
05/11/2000 | WO2000008146A3 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
05/11/2000 | WO2000007728A3 Micro-system with multiple points for chemical or biological analysis |
05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
05/11/2000 | WO2000006777A3 Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
05/11/2000 | WO2000006769A3 Human ccr-2 gene polymorphisms |
05/11/2000 | WO2000005405A3 Lafora's disease gene |
05/11/2000 | WO2000001712A3 Chemically modified proteins with a carbohydrate moiety |
05/11/2000 | WO2000001222A3 Development of novel, highly chemoprotectant crucifer germplasm |
05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
05/11/2000 | WO1999053036A3 Ste20-related protein kinases |
05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
05/11/2000 | DE19940810A1 Biochemical analysis instrument uses mixture of sample and smart reagent beads viewed by color CCD camera to perform chemical analysis of medical samples. |
05/11/2000 | DE19851415A1 New transactivator containing mutant tetracycline repressor, useful e.g. as pharmaceutical and for regulation of gene expression, has amino acids exchanged at selected sites |
05/11/2000 | DE19851413A1 Selecting mutants of a transactivator, useful for regulating gene expression in eukaryotes, by expressing a reporter gene under the control of a mutant transactivator |
05/11/2000 | DE19847364C1 Tumor-Protein Tumor protein |
05/11/2000 | DE19846635A1 New nucleic acid encoding a branching enzyme, useful for in vitro synthesis of branched glucans and to prepare transgenic plants producing modified starch |
05/11/2000 | DE19831639C1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
05/11/2000 | CA2795377A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
05/11/2000 | CA2525148A1 Transgenic and cloned mammals |
05/11/2000 | CA2350692A1 Multiple marker characterization of single cells |
05/11/2000 | CA2350233A1 Transgenic and cloned mammals |
05/11/2000 | CA2350212A1 Treatment of parkinson's disease with oligonucleotides |
05/11/2000 | CA2350168A1 Method for indexing and determining the relative concentration of expressed messenger rnas |
05/11/2000 | CA2350085A1 Methylated cpg island amplification (mca) |
05/11/2000 | CA2349836A1 Method for making complementary oligonucleotide tag sets |
05/11/2000 | CA2349818A1 Membrane transport proteins |
05/11/2000 | CA2349759A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
05/11/2000 | CA2349758A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
05/11/2000 | CA2349505A1 Nucleic acid constructs for genetic immunization |
05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/11/2000 | CA2349495A1 Nucleic acids and polypeptides specific for pathogenic strains of the neisseria genus |
05/11/2000 | CA2349477A1 Regulator of notch signaling activity |
05/11/2000 | CA2349473A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
05/11/2000 | CA2349428A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
05/11/2000 | CA2349417A1 Ikaros isoforms and mutants |
05/11/2000 | CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
05/11/2000 | CA2349212A1 Myosin heavy chain homolog |
05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
05/11/2000 | CA2348962A1 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/11/2000 | CA2348957A1 Detection of negative-strand rna viruses |
05/11/2000 | CA2348938A1 Low allergenic protein variants |
05/11/2000 | CA2348937A1 Method and test kit for analyzing dns repair |
05/11/2000 | CA2348888A1 Novel expression cassette for expressing genes in plant seed |
05/11/2000 | CA2348822A1 Glycosylated proteins having reduced allergenicity |
05/11/2000 | CA2348782A1 A method for genomic substractive hybridization |
05/11/2000 | CA2348779A1 Multidomain polynucleotide molecular sensors |
05/11/2000 | CA2348777A1 Rotavirus subunit vaccine |
05/11/2000 | CA2348774A1 Therapeutic antiangiogenic endostatin compositions |
05/11/2000 | CA2348756A1 Enhanced vaccines |
05/11/2000 | CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases |
05/11/2000 | CA2348745A1 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
05/11/2000 | CA2348737A1 An unusual retrotransposon from the yeast candida albicans |
05/11/2000 | CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
05/11/2000 | CA2348705A1 Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
05/11/2000 | CA2348701A1 Genes and vectors for conferring herbicide resistance in plants |
05/11/2000 | CA2348611A1 Plants having enhanced gall resistance and methods and compositions for producing same |
05/11/2000 | CA2348564A1 Ultrathin-walled multiwell plate for heat block thermocycling |
05/11/2000 | CA2348481A1 Vector for the transformation of phaffia rhodozyma and process of transformation thereby |